Cargando…

Glypican 3 as a Serum Marker for Hepatoblastoma

Hepatoblastoma (HB) is the most common primary liver cancer in children. The conventional serum marker for HB, alpha-fetoprotein (AFP), has its limitations. Novel serum markers need to be explored. Glypican 3 (GPC3) has been reported to be an excellent histological immunomarker for HB. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Shengmei, O’Gorman, Maurice R. G., Yang, Fusheng, Andresen, Kevin, Wang, Larry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381115/ https://www.ncbi.nlm.nih.gov/pubmed/28378832 http://dx.doi.org/10.1038/srep45932

Ejemplares similares

Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma(☆)
por: Shih, Tsung-Chieh, et al.
Publicado: (2020)

Independent Assessment of the Children’s Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis
por: Zhou, Shengmei, et al.
Publicado: (2022)

Glypicans
por: Filmus, Jorge, et al.
Publicado: (2008)

Reduced tumor stiffness quantified by tomoelastography as a predicative marker for glypican-3-positive hepatocellular carcinoma
por: Wang, Yihuan, et al.
Publicado: (2022)

Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma
por: Zhao, Wei, et al.
Publicado: (2015)

Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma
por: Zhao, Juan, et al.
Publicado: (2022)

Somatic glypican 3 (GPC3) mutations in Wilms' tumour
por: White, G R M, et al.
Publicado: (2002)

Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker
por: Levin, Rachel A., et al.
Publicado: (2018)

Expression of glypican 3 in placental site trophoblastic tumor
por: Ou-Yang, Robin J, et al.
Publicado: (2010)

Hepatoblastoma: when to screen?
por: O’Malley, Margaret, et al.
Publicado: (2011)

Methylation analysis of the glypican 3 gene in embryonal tumours
por: Boily, G, et al.
Publicado: (2004)

Cancer immunotherapy‐targeted glypican‐3 or neoantigens
por: Shimizu, Yasuhiro, et al.
Publicado: (2018)

Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
por: El-Saadany, Sherif, et al.
Publicado: (2018)

Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
por: Nishida, Takahiro, et al.
Publicado: (2019)

Evaluation of the association of serum glypican-4 with prevalent and future kidney function
por: Muendlein, Axel, et al.
Publicado: (2022)

Chemiluminescence enzyme immunoassay based on magnetic nanoparticles for detection of hepatocellular carcinoma marker glypican-3
por: Zhang, Qian-Yun, et al.
Publicado: (2011)

Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
por: Wu, Jia-Feng, et al.
Publicado: (2017)

‘Teratoid’ Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma
por: Sergi, Consolato M., et al.
Publicado: (2022)

Increased serum glypican-3 is associated with liver stiffness and hepatic dysfunction in children with biliary atresia
por: Sirisomboonlarp, Kanjaporn, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma
por: Xie, Tan, et al.
Publicado: (2023)

Can glypican-3 be a disease-specific biomarker?
por: Chen, Chaolei, et al.
Publicado: (2017)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients
por: Mauro, Montalbano, et al.
Publicado: (2023)

Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer
por: Fleming, Bryan D., et al.
Publicado: (2016)

Next-Generation Cancer Immunotherapy Targeting Glypican-3
por: Shimizu, Yasuhiro, et al.
Publicado: (2019)

Hepatoblastoma : presentación de un caso clínico /
por: Mora Sarmiento, Laura
Publicado: (1988)

Unresectable hepatoblastoma: current perspectives
por: Trobaugh-Lotrario, Angela D, et al.
Publicado: (2017)

Can Brain Natriuretic Peptides and Osteoprotegerin Serve As Biochemical Markers for the Detection of Aortic Pathology in Children and Adolescents with Turner Syndrome?
por: Mavinkurve, Meenal, et al.
Publicado: (2017)

Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer
por: Han, Shiwei, et al.
Publicado: (2016)

Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
por: Sun, Bin, et al.
Publicado: (2017)

Can Serum Glypican-3 Be a Biomarker for Effective Diagnosis of Hepatocellular Carcinoma? A Meta-Analysis of the Literature
por: Yang, Sheng-Li, et al.
Publicado: (2014)

Expression of Glypican 3 Is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes
por: Rahbari, Mohammad, et al.
Publicado: (2019)

Hepatoblastoma with Precocious Puberty
por: Yhoshu, Enono, et al.
Publicado: (2019)

The Genetic Changes of Hepatoblastoma
por: Chen, Huitong, et al.
Publicado: (2021)

Perinatal risk factors for hepatoblastoma
por: Spector, L G, et al.
Publicado: (2008)

Clinical correlation of calpain-1 and glypican-3 expression with gallbladder carcinoma
por: LUO, WEIQING, et al.
Publicado: (2016)

CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China
por: Huang, Junting, et al.
Publicado: (2020)

Differential expression of syndecans and glypicans in chronically inflamed synovium
por: Patterson, A M, et al.
Publicado: (2008)

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
por: Marin, Jose J. G., et al.
Publicado: (2019)

Expression of Glypican 3 in low and high grade urothelial carcinomas
por: Aydin, Oguz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l2620g5s6c785d09qi05hb25t7